e-learning
resources
Virtual 2021
05.09.2021
Novel insights into the pathogenesis of chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients
s. pavanello (Padova, Italy), M. Campisi (Padova, Italy), F. Liviero (Padova, Italy), D. Biondini (Padova, Italy), E. Balestro (Padova, Italy), P. Spagnolo (Padova, Italy)
Source:
Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Session:
Novel insights into the pathogenesis of chronic lung diseases
Session type:
E-poster
Number:
672
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
s. pavanello (Padova, Italy), M. Campisi (Padova, Italy), F. Liviero (Padova, Italy), D. Biondini (Padova, Italy), E. Balestro (Padova, Italy), P. Spagnolo (Padova, Italy). A rejuvenation effect of the antifibrotic therapy correlates with lung function improvement in IPF patients. 672
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Does atorvastatin have effect on lung function and morbidity as add-on therapy in asthmatic patients?
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007
Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
What influences patient choice of antifibrotic treatment in IPF?
Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world
Year: 2020
Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021
A new method to estimate the long-term effect of immunosuppressants and vasodilator therapies on lung function outcomes in systemic sclerosis patients
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry
Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019
Year: 2020
Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003
The effect of corticosteroid use on skeletal muscle function in patients with interstitial lung disease
Source: Annual Congress 2012 - The latest insights in integrated care
Year: 2012
Assessment of blood biomarkers in patients with IPF under antifibrotic therapy
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
Source: Eur Respir J 2016; 48: 843-851
Year: 2016
Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
The effect of prednisone treatment on lung function test parameters in patients with chronic sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 433s
Year: 2002
Effect of infliximab on lung function and well-being in patients with refractory sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020
The effect of preoperative rehabilitation on pulmonary function in patients with oesophageal cancer
Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation
Year: 2009
Anti-inflammatory effects of targeted lung denervation in patients with COPD
Source: Eur Respir J 2015; 46: 1489-1492
Year: 2015
The impact of insulin-sensitizers on lung function in COPD
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
The effects of sildenafil on lung function in COPD
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Comment on: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J, 57 (3) 2004645; 10.1183/13993003.04645-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept